Article info
Drug therapy
Optimising intravenous salbutamol in children: a phase 2 study
- Correspondence to Dr Sandra Walsh, Paediatric and Neonatal Intensive Care Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK; swalshieis{at}hotmail.com
Citation
Optimising intravenous salbutamol in children: a phase 2 study
Publication history
- Received February 15, 2022
- Accepted December 11, 2022
- First published December 29, 2022.
Online issue publication
March 17, 2023
Article Versions
- Previous version (29 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.